Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Enrolling by invitation × Observational × Echocardiography × Clear all

Status

Completed 8 Recruiting 3 Unknown 2 Active not recruiting 2 Withdrawn 1 Terminated 1 Not yet recruiting 1 Enrolling by invitation 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Melanoma 1 Cardiotoxicity 1

Interventions

Specimen Handling 5 Surveys and Questionnaires 4 Observation 4 Drug Therapy 3 Chemoradiotherapy 3 Blood Specimen Collection 3 Surgical Procedures, Operative 2 Electrocardiography 2 Capecitabine 2 Biopsy 2 trifluridine tipiracil drug combination 1 tegafur-gimeracil-oteracil 1 somapacitan 1 olverembatinib 1 lorlatinib 1 lenvatinib 1 gallium 68 PSMA-11 1 brexucabtagene autoleucel 1 axicabtagene ciloleucel 1 Zoledronic Acid 1 Tegafur 1 Spermine Synthase 1 S 1 (combination) 1 Robotic Surgical Procedures 1 Rituximab 1 Radiotherapy 1 Radiography, Panoramic 1 Radiation 1 Protons 1 Proton Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06605833 2025-10-01

CARD-IO

Royal Marsden NHS Foundation Trust

Enrolling by invitation

Melanoma, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡